Elena Grech

Nine clinical trials on cannabis for insomnia returned largely disappointing results — but the science is far from settled.

A new US federal study finds cancer patients using medical cannabis report fewer symptoms and lower opioid use — findings with real implications for European palliative care.

A large study of 637,000 adolescents suggests self-reported use data may undercount clinically diagnosed cannabis use disorder among young people.

A Swiss pilot study adds to a growing body of evidence that regulated cannabis markets reduce harm rather than increase it.

New neuroimaging research suggests cannabis use alters nicotine processing in the brain — with implications for dual-use consumers across Europe.

Promised regulatory crackdowns in Germany and Australia have stalled, but patients are already paying the price — and European exporters are watching closely.

New research finds habitual cannabis inhalation associated with fewer premature ventricular contractions, raising questions for cardiology.

As cannabis gummies proliferate across European markets, researchers are catching up — but the evidence is more nuanced than the packaging suggests.